Pelvic Microbiomes of Benign and Malignant Ovarian Diseases
- Conditions
- Ovarian NeoplasmsRibosome AlterationMicrobiota
- Interventions
- Diagnostic Test: microbiomes
- Registration Number
- NCT03388996
- Lead Sponsor
- Lei Li
- Brief Summary
This case-control study aims to compare the pelvic microbiomes of benign ovarian diseases and ovarian malignancies by 16s RNA techniques and culture. Discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube are collected from age and menopausal status matched patient before and during procedures of laparoscopies. The discharges/flushing fluid would be sent for 16s RNA analysis and microculture respectively, and the results would get self-contrasted comparison and case-control comparison.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 40
- Laparoscopy procedures
- Specific pathological diagnosis
- Previous history of pelvic surgeries
- Evidences of pelvic inflammation diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Benign ovarian disease microbiomes The group consists of patients of benign ovarian diseases and health conditions (eg infertility), who would accept the tests of pelvic microbiomes. Malignant ovarian disease microbiomes The group consists of patients of high grade serous carcinoma, who would accept the tests of pelvic microbiomes.
- Primary Outcome Measures
Name Time Method Difference of species distribution of microorganism according to 16s RNA analysis 2 years The difference of species of microorganism distribution according to 16s RNA sequencing analysis between control group and study group, and between different sampling sites in each arm
Difference of species distribution of microorganism according to microculture outcomes 2 years Difference of species distribution of microorganism according to microculture outcomes between control group and study group, and between different sampling sites in each arm
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking Union Medical College Hospital
🇨🇳Beijing, Beijing, China